Lidija Beketić-Orešković

Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol).

Charles Dumontet, George E. Durán, Kathleen A. Steger et al. · PubMed · 1996 · 112 citations

Single-step Exposure, Pathology, Tumor Biology +20

Decreased Mutation Rate for Cellular Resistance to Doxorubicin and Suppression of mdrl Gene Activation by the Cyclosporin PSC 833

Lidija Beketić-Orešković, George E. Durán, Kevin G. Chen et al. · JNCI Journal of the National Cancer Institute · 1995 · 84 citations

Tumor markers in breast cancer--evaluation of their clinical usefulness.

Petra Marić, Petar Ozretić, Sonja Levanat et al. · PubMed · 2011 · 79 citations

Brca2 Genes, Prognostic Biomarkers, Breast Oncology +12

A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma

Stjepan Orešković, Damir Babić, Držislav Kalafatić et al. · Gynecologic Oncology · 2004 · 64 citations

Tumoral Pathology, Medicine, Steroid Receptors +7

Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients

Petar Ozretić, Ilija Alvir, Božena Šarčević et al. · The International Journal of Biological Markers · 2017 · 43 citations · Full text